ANCA-associated vasculitis and anti-GBM disease: The experience in China

Nephrology Dialysis Transplantation

Volumn 25, Issue 7, 2010, Pages 2062-2065

  Chen, Min ^a   Cui, Zhao ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

ANCA associated vasculitis; anti GBM disease; China; Keywords

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL;

ANCA ASSOCIATED VASCULITIS; AUTOIMMUNE DISEASE; CHINA; CHINESE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE DISEASE; GOODPASTURE SYNDROME; HISTOPATHOLOGY; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY FAILURE; MICROSCOPIC POLYANGIITIS; NONHUMAN; NOTE; PATHOGENESIS; PATIENT MONITORING; PAUCI IMMUNE GLOMERULONEPHRITIS; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; SURVIVAL RATE; WEGENER GRANULOMATOSIS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; COMPLICATION; IMMUNOLOGY;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CHINA; GLOMERULONEPHRITIS; HUMANS; INCIDENCE;

EID: 77954340763     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq134     Document Type: Note

References (35)

1. Watts RA, Scott DG. Epidemiology of the vasculitides. Curr Opin Rheumatol 2003; 15: 11-16
2. Chen M, Yu F, Zhang Y, Zhao MH. Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic auto-antibody associated systemic vasculitides: a study of 426 patients from a single centre. Postgrad Med J 2005; 81: 723-727
3. Yashiro M, Muso E, Itoh-Ihara T et al. Significantly high regional morbidity of MPO-ANCA-related angitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan). Am J Kidney Dis 2000; 35: 889-895
4. Chen M, Yu F, Zhang Y, Zhao MH. Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore) 2008; 87: 203-209
5. Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY. Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int 2005; 68: 2225-2229
6. Chen M, Kallenberg CG. The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 2009 Epub ahead of print.
7. Franssen C, Gans R, Kallenberg C, Hageluken C, Hoorntje S. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Intern Med 1998; 244: 209-216
8. Hauer HA, Bajema IM, van Houwelingen HC et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 2002; 61: 80-89
9. Lin W, Chen M, Zhao MH. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis. Autoimmunity 2009; 42: 198-202
10. Chen M, Zhao MH. Severe pulmonary hemorrhage in patients with end-stage renal disease in antineutrophil cytoplasmic autoantibody-associated vasculitis. Am J Med Sci 2009; 337: 411-414
11. Chen M, Yu F, Zhao MH. Characteristics of relapses in patients with antineutrophil cytoplasmic autoantibody associated vasculitis: likely to begin with the same organ as initial onset. J Rheumatol 2008; 35: 448-450
12. Chen M, Wang F, Zhao MH. Circulating neutrophil gelatinase associated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis. Rheumatology 2009; 48: 355-358
13. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 2007; 170: 52-64
14. Chen M, Xing GQ, Yu F, Liu G, Zhao MH. Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial Transplant 2009; 24: 1247-1252
15. Xing GQ, Chen M, Liu G, Heeringa P. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoan-tibody associated pauci-immune vasculitis. J Clin Immunol 2009; 29: 282-291
16. Slot MC, Links TP, Stegeman CA, Tervaert JW. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term followup study. Arthritis Rheum 2005; 53: 108-113
17. Zhao MH, Chen M, Gao Y, Wang HY. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int 2006; 69: 1477-1481
18. Gao Y, Zhao MH. Review article: drug-induced anti-neutrophil cyto-plasmic antibody-associated vasculitis. Nephrology (Carlton) 2009; 14: 33-41
19. Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cyto-plasmic auto-antibody-associated vasculitis. Rheumatology (Oxford) 2008; 47: 1515-1520
20. Chen M, Yu F, Wang SX, Zou WZ, Zhao MH, Wang HY. Antineu-trophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol 2007; 18: 599-605
21. Chen M, Kallenberg CGM, Zhao MH. ANCA-negative pauciimmune crescentic glomerulonephritis. Nat Rev Nephrol 2009; 5: 313-318
22. Xing GQ, Chen M, Liu G, Zheng X, E J, Zhao MH. Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis. J Clin Immunol 2010; 30: 144-156
23. Borza DB, Netzer KO, Leinonen A et al. The goodpasture autoanti-gen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem 2000; 275: 6030-6037
24. Appel GB, Radhakrishnan J, D'Agati VSecondary glomerular disease. In: BM Brenner (ed). Brenner and Rector's The Kidney. 8 ed. Philadelphia: Saunders, 2007,; 1093-1094
25. Yang R, Cui Z, Zhao J, Zhao MH. The role of HLA-DRB1 alleles on susceptibility of Chinese patients with anti-GBM disease. Clin Immunol 2009; 133: 245-250
26. Cui Z, Zhao MH, Xin G, Wang HY. Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease. Nephron Clin Pract 2005; 99: c49-c55 (Pubitemid 40187049)
27. Zhao J, Yang R, Cui Z, Chen M, Zhao MH, Wang HY. Characteristics and outcome of Chinese patients with both antineutrophil cytoplas-mic antibody and antiglomerular basement membrane antibodies. Nephron Clin Pract 2007; 107: c56-c62
28. Yang R, Hellmark T, Zhao J et al. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol 2007; 18: 1338-1343
29. Cui Z, Zhao MH, Wang SX, Liu G, Zou WZ, Wang HY. Concurrent antiglomerular basement membrane disease and immune complex glomerulonephritis. Ren Fail 2006; 28: 7-14
30. Cui Z, Wang HY, Zhao MH. Natural autoantibodies against glomer-ular basement membrane exist in normal human sera. Kidney Int 2006; 69: 894-899
31. Yang R, Cui Z, Hellmark T, Segelmark M, Zhao MH, Wang HY. Natural anti-GBM antibodies from normal human sera recognize alpha3 (IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immunol 2007; 124: 207-212
32. Cui Z, Zhao MH. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity. Clin Immunol 2005; 116: 77-82 (Pubitemid 40733585)
33. Cui Z, Zhao MH, Singh AK, Wang HY. Antiglomerular basement membrane disease with normal renal function. Kidney Int 2007; 72: 1403-1408
34. Zhao J, Yan Y, Cui Z, Yang R, Zhao MH. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3 (IV)NC1 is associated with disease severity. Hum Immunol 2009; 70: 425-429
35. Zhao J, Cui Z, Yang R, Jia XY, Zhang Y, Zhao MH. Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity. Kidney Int 2009; 76: 1108-1115